Stay informed with the latest updates for the inheritable blood disorders community.

          Advocacy & Legislative
          Call to Action on Senate Tax Plan
          Call to Action on Senate Tax Plan
          Medical
          THSNA Summit Coming in March 2018
          THSNA Summit Coming in March 2018
          Medical
          Psychosocial Needs of Aging Patients with Hemophilia the Focus of Partners Module
          Psychosocial Needs of Aging Patients with Hemophilia the Focus of…
          Industry
          Alnylam Announces Successful Meeting with FDA on Fitusiran
          Alnylam Announces Successful Meeting with FDA on Fitusiran
          Medical
          NHF Awards Three Judith Graham Pool Postdoctoral Research Fellowships
          NHF Awards Three Judith Graham Pool Postdoctoral Research Fellowships
          Medical
          NHF-McMasters Guidelines on ECRI
          New Educational Webinars for Healthcare Providers Outside Hematology
          Industry
          Study Shows Positive Joint Outcomes in Hemophilia A Patients Treating Prophylactically with ELOCTATE®
          Study Shows Positive Joint Outcomes in…
          Industry
          ICER Review of Emicizumab for People with Hemophilia A and Inhibitors
          FDA Accepts Application for Bayer’s Investigational Hemophilia A Therapy
          Industry
          FDA Grants Breakthrough Therapy Designation for BioMarin’s Investigative Hemophilia A Gene Therapy
          FDA Grants Breakthrough Therapy Designation for…
          Medical
          New Medscape Activity Describes Latest Advances in Inhibitor Management
          Partners Clinical Management Module Focuses on ITI and Inhibitors
          Industry
          Shire’s Hemophilia Gene Therapy Granted Orphan Drug Status by FDA
          Shire’s Hemophilia Gene Therapy Granted Orphan Drug Status by FDA
          Advocacy & Legislative
          Joint Endorsement of Alexander-Murray
          Joint Endorsement of Alexander-Murray
          Industry
          uniQure Announces First Hemophilia B Patient Treated in Phase III Gene Therapy Trial
          UniQure’s Investigational Hemophilia B Gene Therapy to Move Forward in…
          Medical
          New Study Demonstrates Potential for Reducing Factor VIII Inhibitors in Hemophilia A
          New Study Demonstrates Potential for Reducing Factor VIII…
          Advocacy & Legislative
          NHF Healthcare Update: Trump Executive Order and Cost-Sharing Reductions Changes
          NHF Healthcare Update: Trump Executive Order and Cost-Sharing…